NASDAQ:ARWR
Arrowhead Pharmaceuticals, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Selectwebsite
arrowheadpharma.comipo date
Dec 14, 1993full time employees
397currency
USD
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus